September 01, 2025

Initial DIAMOND Results Support OCS-01 Efficacy

Breakthrough results in diabetic macular edema treatment presented at Euretina 2025 highlight significant visual gains with OCS-01 eye drops.

Retinal Physician

August 26, 2025

FDA Begins Real-Time Reporting of Adverse Event Data

According to the FDA, the shift is one of many steps in the agency’s broader data modernization strategy to streamline all of its adverse event reporting systems and increase reporting frequency across all systems to identify safety signals faster.

Ophthalmology Management

August 11, 2025

4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME

The positive results from the SPECTRA trial demonstrate the tolerability and consistent, durable clinical activity of 4D-150 in DME.

Ophthalmology Management

August 12, 2025

Ocular Therapeutix Announces FDA Approves NPDR Trial Plan for OTX-TKI

A Special Protocol Assessment (SPA) establishes a regulatory path for Ocular Therapeutix’s Axpaxli in diabetic eye disease.

Ophthalmology Management

July 01, 2025

Rapid Developments in Geographic Atrophy

The first treatments for GA were approved just 2 years ago, in 2023. While they slow progression, there’s a need for agents that would ideally prevent or reverse GA—or that would slow GA progression to a greater degree.

Ophthalmology Management

February 26, 2025

Integration of Vision Services Remains an Unmet Need in FQHCs

Telemedicine, funding, and provider partnerships can help, researchers say.

Conexiant

April 09, 2025

Port Delivery System With Ranibizumab for Diabetic Eye Disease

Researchers determined that the PDS may decrease the treatment burden of frequent intravitreal injections, but further research on efficacy and safety is needed.

Conexiant

January 16, 2025

LA County Fires Prompt Business Recovery Centers to Open

"Business owners can meet face-to-face with specialists to apply for disaster loans and access a wide range of resources to guide them through their recovery."

Optometric Management

April 02, 2025

GLP-1 RAs Evaluated for Long-Term Risk of NAION in Patients With Diabetes

Researchers’ subgroup analyses provide data on increased risks according to timepoint, demographics, and comorbidities.

Conexiant